Istituto di Candiolo - IRCCS

The Institute for Cancer Research is a private non-profit institution founded and supported by the Fondazione Piemontese per la Ricerca sul Cancro-Onlus (FPRC) and operated by the Fondazione del Piemonte per l'Oncologia (FPO: a joint venture between the FPRC and the Regione Piemonte). It is linked to the Department of Oncology of the University of Torino. Its mission is a significant contribution to fight cancer, by understanding the basics, and by providing state-of-the-art diagnostic and therapeutic services. At the core of the Institute is the interface between molecular biology and medicine. The FPRC provides enduring fund raising to complete and develop the Institute's buildings and technologies to foster research.

AIRC Special Program in Clinical Molecular Oncology

"Molecular Clinical Oncology" is a novel discipline translating biology into medicine. Targeting single genetic lesions can interfere with tumor growth notwithstanding the multitude of genetic alterations harbored by cancers. This has given an unprecedented clinical value to the concept that cancer is a disease of genes, a dogma in molecular oncology that is now practically exploited by clinicians to set up novel classifications of tumors based on the presence of defined genetic lesions. Thanks to these advances, the idea of giving a patient a drug tailored to the genetic makeup of the tumor is becoming commonplace.


MET signaling in colon cancer stem-...
Blockade of EGFR and MEK Intercepts...
Liquid Biopsies: Genotyping Circula...



Tuesday 25 November 2014
Dr. Margaret Foti, PhD, MD (hc)
Reflections on the Global Cancer Research Landscape


Istituto di Candiolo
Strada Provinciale, 142 km 3,95
10060 Candiolo, Torino-Italy


How to reach the Institute

Visualizza IRCC in una mappa di dimensioni maggiori

Support Us